神經元科技榮獲經濟部中小企業創新研究獎
很開心跟大家分享這個好消息：神經元科技旗下的NeuroSwift Pro智慧神經眼動診斷系統在今年度獲得經濟部中小企業創新研究獎的肯定。這項獎項主要表揚在研發深度、技術創新與產業影響力上具有代表性的中小企業。
NeuroSwift Pro將醫療級眼動追蹤技術與AI演算法整合，協助臨床評估多項神經功能，包括眼動控制、腦幹功能、動態視覺處理、注意力反應與神經可塑性等指標，並提升診斷流程的客觀化與效率。目前已陸續導入國際多家醫學中心與區域醫院使用，也在市場獲得醫療單位與合作夥伴的高度興趣。
感謝長期支持神經元的醫療夥伴、研究團隊與全球合作伙伴，未來我們將持續以眼動與AI為核心，開發更多可在臨床與社會真正創造價值的腦健康科技。
NeuroSwift Pro將醫療級眼動追蹤技術與AI演算法整合，協助臨床評估多項神經功能，包括眼動控制、腦幹功能、動態視覺處理、注意力反應與神經可塑性等指標，並提升診斷流程的客觀化與效率。目前已陸續導入國際多家醫學中心與區域醫院使用，也在市場獲得醫療單位與合作夥伴的高度興趣。
感謝長期支持神經元的醫療夥伴、研究團隊與全球合作伙伴，未來我們將持續以眼動與AI為核心，開發更多可在臨床與社會真正創造價值的腦健康科技。
Nov 24, 2025
Neurobit Partners with Recon Supply to Modernize Vestibular Diagnostics in VA and DoD Hospitals
AI-powered eye-tracking delivers faster, objective assessments to improve care for veterans
Neurobit Technologies (https://www.neurobittech.com/), an innovative medtech startup specializing in AI-powered eye-tracking and vestibular assessment, today announced a strategic partnership with Recon Supply (www.recon-supply.com/), a veteran-owned medical equipment distributor serving U.S. Department of Veterans Affairs (VA) and the Department of Defense (DoD) healthcare systems.
The partnership combines Neurobit’s intelligent neurological technology with Recon Supply’s federal-contracting expertise to bring faster, objective vestibular diagnostics into hospitals and clinics caring for veterans and active-duty personnel. Veterans frequently experience dizziness, balance disorders, and vertigo, often resulting from traumatic brain injuries (TBI), blast exposures, and age-related conditions. Data shows the disparity: 24.3% of male veterans report balance problems, compared to 18.7% of nonveteran men. Among veterans with TBI, 92% report imbalance and 53% report vertigo. Current diagnostic methods can be subjective, specialist-dependent, and time-consuming, with traditional tests taking up to an hour.
Neurobit’s flagship product, NeuroSwift™ Pro with AIVertigo, is an FDA Class II medical device that provides an integrated, AI-assisted eye-movement diagnostic solution, rapidly assess brain function, stratify risk, and streamline triage in 10 minutes or less. “It’s a major milestone to partner with Recon Supply”, said Travis Yang, Co-Founder and CEO of Neurobit Technologies, “ as this will accelerate clinical adoption and help modernize VA healthcare system with data-supported, time-saving and cost-effective solutions.”
As part of the collaboration, a pilot program will launch at selected VA hospitals, providing neurologists, ENT specialists and primary-care physicians to experience the real-world clinical impact.“Working with Neurobit aligns with our mission to deliver advanced, veteran-centric technologies across VA and DoD healthcare systems,” said Stephen Clark, Founder of Recon Supply. “As a veteran myself, I’m product to bring this innovative solution to care for my veteran peers, who care for our nation. Together, we can enhance both clinical accuracy and patient outcomes.”
About Neurobit
Neurobit Technologies develops advanced diagnostic systems that reveal brain and vestibular function through eye movement. Its products, including NeuroSwift, NeuroSwift Pro, and AIVertigo, are trusted by hospitals and research centers worldwide, providing reliable, real-time data to support early diagnosis, clinical decision-making, and patient monitoring.
About Recon Supply
Recon Supply is a veteran-owned medical device distributor that specifically provides equipment and solutions to U.S. federal healthcare agencies, including VA and DoD hospitals. The company connects emerging med-tech innovations with the needs of military and veteran healthcare providers.
Neurobit Technologies Contact:
Daphne Wang Stubbs
www.neuorbittech.com
Neurobit Technologies (https://www.neurobittech.com/), an innovative medtech startup specializing in AI-powered eye-tracking and vestibular assessment, today announced a strategic partnership with Recon Supply (www.recon-supply.com/), a veteran-owned medical equipment distributor serving U.S. Department of Veterans Affairs (VA) and the Department of Defense (DoD) healthcare systems.
The partnership combines Neurobit’s intelligent neurological technology with Recon Supply’s federal-contracting expertise to bring faster, objective vestibular diagnostics into hospitals and clinics caring for veterans and active-duty personnel. Veterans frequently experience dizziness, balance disorders, and vertigo, often resulting from traumatic brain injuries (TBI), blast exposures, and age-related conditions. Data shows the disparity: 24.3% of male veterans report balance problems, compared to 18.7% of nonveteran men. Among veterans with TBI, 92% report imbalance and 53% report vertigo. Current diagnostic methods can be subjective, specialist-dependent, and time-consuming, with traditional tests taking up to an hour.
Neurobit’s flagship product, NeuroSwift™ Pro with AIVertigo, is an FDA Class II medical device that provides an integrated, AI-assisted eye-movement diagnostic solution, rapidly assess brain function, stratify risk, and streamline triage in 10 minutes or less. “It’s a major milestone to partner with Recon Supply”, said Travis Yang, Co-Founder and CEO of Neurobit Technologies, “ as this will accelerate clinical adoption and help modernize VA healthcare system with data-supported, time-saving and cost-effective solutions.”
As part of the collaboration, a pilot program will launch at selected VA hospitals, providing neurologists, ENT specialists and primary-care physicians to experience the real-world clinical impact.“Working with Neurobit aligns with our mission to deliver advanced, veteran-centric technologies across VA and DoD healthcare systems,” said Stephen Clark, Founder of Recon Supply. “As a veteran myself, I’m product to bring this innovative solution to care for my veteran peers, who care for our nation. Together, we can enhance both clinical accuracy and patient outcomes.”
About Neurobit
Neurobit Technologies develops advanced diagnostic systems that reveal brain and vestibular function through eye movement. Its products, including NeuroSwift, NeuroSwift Pro, and AIVertigo, are trusted by hospitals and research centers worldwide, providing reliable, real-time data to support early diagnosis, clinical decision-making, and patient monitoring.
About Recon Supply
Recon Supply is a veteran-owned medical device distributor that specifically provides equipment and solutions to U.S. federal healthcare agencies, including VA and DoD hospitals. The company connects emerging med-tech innovations with the needs of military and veteran healthcare providers.
Neurobit Technologies Contact:
Daphne Wang Stubbs
www.neuorbittech.com
Oct 13, 2025
NeuroSwift Pro智慧神經眼動診斷系統榮獲「2025臺北生技獎」銀獎！
「生技產業奧斯卡」之稱的 2025臺北生技獎於日前舉行頒獎典禮，我們的 NeuroSwift Pro智慧神經眼動診斷系統榮獲創新技術獎（醫療器材組）銀獎 的殊榮！
NeuroSwift Pro專為中樞與周邊性眩暈鑑別、腦神經風險篩檢設計，結合高解析眼球運動追蹤與視覺誘發測試，可應用於神經內科、耳鼻喉科與健康檢查。系統內建AI自動分析模組，即時判讀眼動特徵並生成報告，協助醫師快速辨識腦幹、前庭與眼動功能異常。
未來，神經元將持續推動不同模組、遠距評估與多病症預警的開發，打造智慧神經診斷平台的新典範。
NeuroSwift Pro專為中樞與周邊性眩暈鑑別、腦神經風險篩檢設計，結合高解析眼球運動追蹤與視覺誘發測試，可應用於神經內科、耳鼻喉科與健康檢查。系統內建AI自動分析模組，即時判讀眼動特徵並生成報告，協助醫師快速辨識腦幹、前庭與眼動功能異常。
未來，神經元將持續推動不同模組、遠距評估與多病症預警的開發，打造智慧神經診斷平台的新典範。
Sep 30, 2025
2025 高齡健康產業博覽會｜腦健康快篩會後回顧
在今年的高齡健康產業博覽會中，我們運用NeuroSwift Pro針對136位21歲以上民眾進行腦健康快篩。透過這項活動，我們可初步了解成人腦健康的現況，並將檢測結果轉化為衛教資訊，協助民眾在早期就能察覺潛在腦功能異常，守護長期健康。
檢測結果顯示，低或正常風險族群占比92%，而高風險與中風險族群各占4%，換言之，約8%的受測者已出現潛在腦健康異常，這可能反映早期腦功能退化的訊號。值得注意的是，多數受測者自覺健康，但透過NeuroSwift Pro眼動與平衡測試，仍有部分族群存在早期異常風險。
這些檢測結果顯示，眼動與平衡功能其實反映了多個關鍵腦區的健康狀態。小腦負責動作協調與精準度，異常時可能出現步態不穩、手抖或眼球追蹤異常；腦幹則整合來自前庭系統（內耳平衡）、視覺與本體感覺的訊號，是維持姿勢與穩定的核心中樞；而基底核則與動作的啟動與控制密切相關，一旦受影響，可能會出現僵硬、顫抖或動作遲緩。這些腦區的功能障礙往往在記憶力衰退之前就會浮現，因此在臨床觀察中，許多神經退化疾病的早期徵兆，常先表現在平衡異常、眼球運動異常或步態變化上。藉由神經元的腦健康快篩，我們能在日常生活還未出現明顯症狀之前，便提早辨識腦健康風險，盡早介入並採取保養措施。
至於日常維護腦部健康，除了定期檢測之外，更需要從生活型態著手：規律的有氧運動與平衡訓練能活化神經連結；均衡飲食如攝取足夠的 Omega-3、抗氧化食物與多酚能降低腦部發炎；良好的睡眠則協助代謝清除腦內廢物；而持續學習、參與社交互動，則能保持神經網絡活躍。這些日常選擇雖然看似簡單，卻能在長期累積下有效延緩腦部退化，守護健康老化的關鍵基礎。
腦健康快篩不僅評估眼動與平衡，更是一種結合AI與眼球運動分析的早期腦功能監測工具。透過定期檢測與數據追蹤，我們能在症狀尚未出現前掌握自身腦健康狀態，提前採取保養行動，守護健康老化。
在本次 136 位受測者中，女性比例約占 79%，男性約 21%，顯示女性族群對腦健康檢測的參與度較高。年齡分布則以 61–70 歲最多（41%），其次為 51–60 歲（24%）與 41–50 歲（11%），而 21–40 歲及 71 歲以上族群則分別占 7% 與 17%。這樣的參與分布提醒我們，腦健康並不是專屬於老年的議題，而是每個世代都需要及早關注與持續經營的長期健康課題。
檢測結果顯示，低或正常風險族群占比92%，而高風險與中風險族群各占4%，換言之，約8%的受測者已出現潛在腦健康異常，這可能反映早期腦功能退化的訊號。值得注意的是，多數受測者自覺健康，但透過NeuroSwift Pro眼動與平衡測試，仍有部分族群存在早期異常風險。
這些檢測結果顯示，眼動與平衡功能其實反映了多個關鍵腦區的健康狀態。小腦負責動作協調與精準度，異常時可能出現步態不穩、手抖或眼球追蹤異常；腦幹則整合來自前庭系統（內耳平衡）、視覺與本體感覺的訊號，是維持姿勢與穩定的核心中樞；而基底核則與動作的啟動與控制密切相關，一旦受影響，可能會出現僵硬、顫抖或動作遲緩。這些腦區的功能障礙往往在記憶力衰退之前就會浮現，因此在臨床觀察中，許多神經退化疾病的早期徵兆，常先表現在平衡異常、眼球運動異常或步態變化上。藉由神經元的腦健康快篩，我們能在日常生活還未出現明顯症狀之前，便提早辨識腦健康風險，盡早介入並採取保養措施。
至於日常維護腦部健康，除了定期檢測之外，更需要從生活型態著手：規律的有氧運動與平衡訓練能活化神經連結；均衡飲食如攝取足夠的 Omega-3、抗氧化食物與多酚能降低腦部發炎；良好的睡眠則協助代謝清除腦內廢物；而持續學習、參與社交互動，則能保持神經網絡活躍。這些日常選擇雖然看似簡單，卻能在長期累積下有效延緩腦部退化，守護健康老化的關鍵基礎。
腦健康快篩不僅評估眼動與平衡，更是一種結合AI與眼球運動分析的早期腦功能監測工具。透過定期檢測與數據追蹤，我們能在症狀尚未出現前掌握自身腦健康狀態，提前採取保養行動，守護健康老化。
在本次 136 位受測者中，女性比例約占 79%，男性約 21%，顯示女性族群對腦健康檢測的參與度較高。年齡分布則以 61–70 歲最多（41%），其次為 51–60 歲（24%）與 41–50 歲（11%），而 21–40 歲及 71 歲以上族群則分別占 7% 與 17%。這樣的參與分布提醒我們，腦健康並不是專屬於老年的議題，而是每個世代都需要及早關注與持續經營的長期健康課題。
Sep 2, 2025
Neurobit Technologies Unveils FDA 510(k) Clearance for NeuroSwift Pro:
An Advanced Solution for Efficient Vestibular Disorder Identification
Aug 15, 2023
2022/12 Updates
Taipei, Taiwan – We are thrilled to announce that we have been named a CES® 2023 Innovation Awards Honoree for NeuroSwift. This year’s CES Innovation Awards program received a record high number of over 2100 submissions. The announcement was made ahead of CES 2023, the world’s most influential technology event, happening Jan. 5-8 in Las Vegas, NV.
|
The CES 2023 Innovation Awards HonoreesProduct descriptions and photos can be found at CES.tech/innovation. More will be revealed in January. Many honorees will showcase their winning products in the Innovation Awards Showcase at CES 2023.
|
NeuroSwift
NeuroSwift is an 100 percent in-house developed wearable smart medical device solution. It is designed to provide a complete solution for clinicians to identify patients with potential eye movement disorders and strabismus. The cameras inside the goggles will capture the eye movement of the patients, and the AI computer vision software will analyze the obtained data to generate analytic report. With the AI and machine learning software, NeuroSwift enables remote patient monitoring and consultation from any location with high quality videos and analytic reports, providing comprehensive communication.
About Neurobit
With the aim of providing revolutionary technology to the medical community, Neurobit integrated both hardware and software system from eye to brain which leverages artificial intelligence and machine learning for improved diagnostic precision that eases the lives of healthcare professionals around the globe. Our mission is to solve unmet neuro-clinical needs and offer a triple-win solution to professionals, patients and insurance companies.
|
December 31, 2022
|
